skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines pirfenidoneQuestion & answer

pirfenidone · Medicine question

What condition is Esbriet (pirfenidone) indicated to treat in adults?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Esbriet (pirfenidone) is indicated to treat idiopathic pulmonary fibrosis (IPF) in adults.

Sources for this answer

Esbriet 267 mg, 801 mg Film-coated TabletsRoche Products Limited · emc · SmPC §4.1 Therapeutic Indications · Version 14Document updated 29 January 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about pirfenidone

Do Esbriet (pirfenidone) 267 mg and 801 mg film-coated tablets require special storage conditions?How much sodium does each Esbriet (pirfenidone) tablet contain?How should unused Esbriet (pirfenidone) film-coated tablets or waste material be disposed of?Is Esbriet (pirfenidone) contraindicated in patients with severe renal impairment or end-stage renal disease requiring dialysis?Should Esbriet (pirfenidone) film-coated tablets be swallowed whole?What do Esbriet (pirfenidone) 267 mg film-coated tablets look like?

pirfenidone

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the pirfenidone guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX